B of A Securities analyst Michael Feniger upgrades GFL Envirn (NYSE:GFL) from Neutral to Buy and announces $32.5 price target.
Analyst Expectations for ACADIA Pharmaceuticals’s Future
Within the last quarter, ACADIA Pharmaceuticals (NASDAQ:ACAD) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…